Session Information
AABB Annual Meeting and CTTXPO 2012
Click here to go to the previous page
New Cellular Therapy of Cancer: T Cells, NK Cells and GVL AABB/ASBMT Joint Program
Track
:
TC - Technical/Clinical
Program Code:
9317-TC-CT
Date:
Monday, October 8, 2012
Time:
2:00 PM to 3:30 PM
EST
Location:
206A/B
DIRECTOR
:
Daniel Weisdorf, MD, Professor of Medicine; Director of the Adult Blood and Marrow Transplant Program, University of Minnesota
MODERATOR
:
Daniel Weisdorf, MD, Professor of Medicine; Director of the Adult Blood and Marrow Transplant Program, University of Minnesota
SPEAKER
(S):
Michael Kalos, PhD, Associate Professor, University of Pennsylvania
Sarah Cooley, MD, MS, Assistant Professor of Medicine, University of Minnesota
Daniel Weisdorf, MD, Professor of Medicine; Director of the Adult Blood and Marrow Transplant Program, University of Minnesota
Description
New approaches for adoptive cell therapy can control cancers that are not responsive to other techniques. T lymphocytes can be targeted towards tumor-associated antigens; NK cells can induce in vivo anti-cancer responses and both have been applied. Their use and current research approaches will be reviewed. The most widely applied anti-cancer cell therapy is allogeneic hematopoitic cell (blood or marrow) transplantation. It incorporates the graft-vs-tumor or graft-vs-leukemi (GVL) effect. Current understanding of GVL responses will be discussed.
- Understand how cellular therapy can be developed as anticancer treatment.
- Understand how T cells or natural killer (NK) cells can be used for adoptive anti-cancer cellular therapy.
- Understand the graft-vs-tumor effect accompanying allogeneic hematopoietic cell transplantation.
| CE Category | CE Value |
|---|---|
| California Clinical Laboratory Personnel | 1.5 |
| California Nurse | 1.8 |
| Florida Laboratory Personnel | 1.8 |
| General Attendee | 1.5 |
| Physician | 1.5 |
Please note: Continuing education (CE) credit is available for online offerings only. Individuals that purchase CD-ROMs will not receive CE credit for the programs they view.
Online Access
(Code: 9317-TC-CTAM/9317-TC-CT/9317-TC-CTA/9317-TC-CT)
Annual Meeting Attendee/AABB Member:$25 USD
Non-Attendee/AABB Member:$40 USD
Annual Meeting Attendee/Non AABB Member:$40 USD
Non-Attendee/Non AABB Member $50 USD - Your Price
This session is a part of:
This session is a part of:
 | Copyright © 2014 by MultiView, Inc. All website graphics, text, design, software, and other works are the copyrighted works of MultiView, Inc. All audio, video, presentation materials, logos and text are the copyrighted works of their respective owners. All Rights Reserved. Any redistribution or reproduction of any materials herein is strictly prohibited. |  |